BIODESIX INC (67) | Uncategorized (13)
Recent Contracts
-
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 16, 2021)
-
Letter from Bio-Rad Laboratories, Inc. dated August 7, 2020
(Filed With SEC on October 21, 2020)
-
Letter from Bio-Rad Laboratories, Inc. dated August 14, 2020
(Filed With SEC on October 21, 2020)
-
Form of Option Agreement under the Biodesix, Inc. Bonus-To-Options Program
(Filed With SEC on October 9, 2020)
-
Biodesix, Inc., First Amended Bonus-to-Options Program, adopted by the Board of Directors on October 15, 2010
(Filed With SEC on October 2, 2020)
-
Biodesix, Inc., Second Amended Bonus-to-Options Program, adopted by the Board of Directors on June 21, 2011
(Filed With SEC on October 2, 2020)
-
Biodesix, Inc., Third Amended Bonus-to-Options Program, adopted by the Board of Directors on December 31, 2015
(Filed With SEC on October 2, 2020)
-
Contingent Value Rights Agreement between Biodesix, Inc. and Holders on Schedule A mentioned within, dated February 22, 2016
(Filed With SEC on October 2, 2020)
-
Contract Agreement between Biodesix, Inc. and the Colorado Department of Public Health and Environment, dated September 11, 2020
(Filed With SEC on October 2, 2020)
-
Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated March 23, 2020
(Filed With SEC on October 2, 2020)
-
First Amendment to Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc. dated April 3, 2020
(Filed With SEC on October 2, 2020)
-
Material Transfer Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated April 17, 2020
(Filed With SEC on October 2, 2020)
-
Price Agreement by and between Biodesix, Inc. and Bio-Rad Laboratories, Inc., dated May 12, 2020
(Filed With SEC on October 2, 2020)